Personalis
Founders
Russ Altman M.D., Ph.D. - Founder
Euan Ashley M.D., Ph.D. - Founder
Atul Butte M.D., Ph.D. - Founder
Michael Snyder Ph.D. - Founder
Christopher Hall - CEO
Founded
2011
Stage
Series A
Invested
2011
Status
IPO
Lightspeed Team
Christopher Schaepe - Partner
Jonathan MacQuitty - Partner

Personalis combines world class expertise in the technology of genome sequencing and interpretation with an extensive track record of peer-reviewed publications to transform the development of next-generation cancer therapies by providing more comprehensive molecular data about each patient’s tumor.

The company completed an IPO in 2019.

Jonathan MacQuitty